• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Proton pump inhibitor use associated with development of chronic kidney disease

byAnees DaudandJames Jiang
January 11, 2016
in Chronic Disease, Gastroenterology, Nephrology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. Amongst two prospective cohorts, use of proton pump inhibitors (PPIs) was associated with a 20 – 50% higher risk of developing chronic kidney disease (CKD). This same risk was not present with the use of H2-antagonists, which are prescribed for the same indications as PPIs.

2. Given the high prevalence of PPI use, often without an indication or for longer than indicated, this association has important implications given the morbidity and mortality related to CKD.

Evidence Rating Level: 2 (Good)

Study Rundown: Chronic kidney disease (CKD) leads to significant morbidity and mortality amongst the American population, and is a major economic burden. While co-morbid conditions such as diabetes and hypertension are known to cause and exacerbate CKD, polypharmacy has also been implicated. Proton pump inhibitors (PPIs), which are one of the most prescribed medications, often without a strong indication, have been linked to acute kidney injury (AKI). The theory is that recurrent bouts of AKI may lead to CKD. This study, which used data from two prospective cohorts, was conducted to evaluate the link between PPIs and incident CKD. The results of the study showed that use of proton pump inhibitors (PPIs) was associated with about 20 – 50% higher risk of developing chronic kidney disease (CKD). This same risk was not present with the use of H2-antagonists, which are prescribed for the same indications as PPIs.

The strength of this study was the use of two prospective cohorts to evaluate the relationship between PPIs and CKD, which strengthens the validity of the results. Drawbacks are the observational nature of the study, which has inherent problems with assigning causality. Also, one of the cohorts uses ICD9 codes to identify CKD, which may have led to misdiagnosis.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Risk of chronic kidney disease progression may be greater amongst patients with obstructive sleep apnea

Wellness Check: Sleep

Post-COVID Syndrome is linked to higher mortality risk and multi-organ dysfunction

Relevant Reading: Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study

In-Depth [prospective cohort]: The purpose of this study was to evaluate a possible link between use of PPIs and development of CKD. This study comprised of two prospective cohorts: Atherosclerosis Risk in Communities (ARIC) cohort and Geisinger Health System cohort. The former was a population-based cohort from four states, and the latter was a cohort from a rural health care system. In addition to demographic and co-morbid characteristics, the study characteristics were use of PPIs (and H2-antagonists as a comparator) and incident CKD, based on health care documentation.

The study showed that in the ARIC cohort, after adjustment of potential confounders, users of PPI had a higher risk of incident CKD compared to non-users of PPIs (HR 1.50; 95% CI, 1.14 – 1.96). A similar finding was present in the Geisinger cohort (HR 1.17; 95% CI, 1.12 – 1.23). The risk developing AKI was even higher amongst patients using PPIs in the ARIC (HR 1.64; 95% CI, 1.22 – 2.21) and the Geisinger cohort (HR 1.31; 95% CI, 1.22 – 1.42). When comparing PPI use to H2-antagonist use, the former was associated with a higher risk of developing CKD in both the ARIC cohort (HR 1.39; 95% CI, 1.01 – 1.91) and the Geisinger cohort (HR 1.29; 95% CI, 1.19 – 1.4). The use of H2-antagonists was not associated with developing CKD.

Image: CC/Wiki/Nephron

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic kidney diseasePPI
Previous Post

2 Minute Medicine Rewind January 11, 2016

Next Post

Age and breast cancer risk factors associated with false-positive mammography results

RelatedReports

CPAP may not decrease cardiovascular events in sleep apnea
Nephrology

Risk of chronic kidney disease progression may be greater amongst patients with obstructive sleep apnea

March 14, 2022
Decline in adolescent sleep duration over past 20 years
Wellness

Wellness Check: Sleep

March 10, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Infectious Disease

Post-COVID Syndrome is linked to higher mortality risk and multi-organ dysfunction

April 14, 2021
#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction
StudyGraphics

#VisualAbstract: Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD Increases Risk of Major Cardiovascular Events and Mortality

January 13, 2021
Next Post
Age and breast cancer risk factors associated with false-positive mammography results

Age and breast cancer risk factors associated with false-positive mammography results

USPSTF recommends biennial screening mammography in 50 to 74 year-old women

USPSTF recommends biennial screening mammography in 50 to 74 year-old women

Epidural corticosteroid injections provide only short-term radiculopathy pain relief

Education combined with exercise linked to reduction of low-back pain episodes

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wellness Check: Sleep
  • Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events
  • Early onset Lewy Body Dementia is more clinically distinct from Alzheimer Dementia than late onset Lewy Body Dementia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.